Table of ContentsView AllTable of ContentsSymptomsCausesDiagnosisTreatmentPrognosis
Table of ContentsView All
View All
Table of Contents
Symptoms
Causes
Diagnosis
Treatment
Prognosis
Anaplastic astrocytoma is a rare malignant brain tumor. It develops from astrocyte cells that normally protect nerve cells in the brain and spinal cord.
Anaplastic astrocytomas are grade III astrocytomas. According to the World Health Organization (WHO), there are four grades of astrocytoma.The higher the grade, the faster the cancer cells are reproducing and the more likely the tumor will spread.
Verywell / Joules Garcia
Anaplastic Astrocytoma Symptoms
This buildup of pressure can cause the following symptoms:
Symptoms of anaplastic astrocytoma can be specific to the area of the brain where the tumor has developed. Other symptoms may include tingling or burning sensations, balance problems, difficulties communicating, vision problems, and back pain.
Seizures are acommon symptomfor many brain tumors, but they are less common as an initial symptom in people with anaplastic astrocytoma.
Focal seizuresare one kind of seizure seen in brain tumors. Symptoms of focal seizures can include involuntary movements (twitches) of a small part of the body, decreased alertness, or a complete lack of awareness.
Most anaplastic astrocytoma tumors develop slowly and over time. However, in some cases, the tumor develops rapidly, and this can cause symptoms to appear suddenly.
You can have one or more of these symptoms. If you have any of these symptoms, be sure to see your doctor so they won’t worsen.
The specific cause of anaplastic astrocytoma is unknown. However, it is thought that certain genetic, environmental, and lifestyle factors are linked to its development.
Risk factors for anaplastic astrocytoma include:
One factor linked to a reduced risk of developing anaplastic astrocytomas is having allergies or atopic dermatitis, which includes allergic skin diseases such as eczema.It is not known why this is the case.
Genetics
The majority of anaplastic astrocytoma cases are not inherited, meaning they do not pass from parents to children. However, there are a few rare, inherited disorders linked to an increased risk of anaplastic astrocytoma. They are:
Scientists have discovered genetic mutations that they believe are linked to anaplastic astrocytoma.Having these genetic mutations means that someone is genetically predisposed to this type of brain cancer. However, that does not mean they will definitely develop anaplastic astrocytoma.
While there are signs and symptoms that may indicate the existence of this type of brain tumor, they are not sufficient for a diagnosis of anaplastic astrocytoma.
An imaging procedure, such as a magnetic resonance imaging (MRI) or computed tomography (CT) scan, will be done. A brain biopsy (the removal and evaluation of the tumor’s tissue) is needed to confirm the diagnosis.
The medical team will need to differentiate between anaplastic astrocytoma and other types of brain tumors such as:
Anaplastic astrocytomas also share many symptoms with other, non-brain tumor conditions. These are:
In most cases, the first-line treatment for anaplastic astrocytoma is surgery, which aims to remove the tumor or as much of it as possible.
Since anaplastic astrocytomas can occur in or near areas of thebrainthat control bodily functions such as movement, sensation, language, and vision, special measures must be taken in surgery to monitor and protect these functions.
Anaplastic astrocytomas tend to spread into neighboring healthy tissue. This means that it can be difficult to fully remove all cancer cells.
Sometimes surgery is not possible if the tumor is in an area where vital functions may be damaged, such as if the tumor is near a major blood vessel or in the brain stem.
The specific treatment plan will be based on a number of factors, including where the tumor is and whether it has spread to other areas, as well as the patient’s age and general health.
Many gliomas show a mutation in a gene that codes for isocitrate dehydrogenase (IDH), an enzyme important in energy metabolism.These mutations can contribute to the growth and invasiveness of the tumor. Drugs and vaccines are being developed to target IDH.
Your doctor and other members of your health team will help you decide what the best therapies are for you. Your doctor should also go through with you all the potential risks and benefits of each therapy before your treatment plan is made.
Remember to ask lots of questions and bring up any of your concerns.
There are few studies that focus exclusively on patients with anaplastic astrocytoma. A 2018 study looked at 100 patients between 6 and 68 years of age with anaplastic astrocytoma or anaplastic oligodendroglioma. Eighty-four patients had follow-up details and were included for survival analysis. The five-year overall survival rate for anaplastic astrocytoma was 52 percent.
Patients who received adjuvant chemotherapy with the chemotherapeutic agent Temodar (temozolomide) were found to have an increased chance of survival over five years than those who did not.
It is important to note that a number of factors play into survival, including age, the patient’s ability to function mentally or physically, and the presence or absence of a number of mutations.
Summary
Anaplastic astrocytoma is a rare form of cancerous brain tumor. Its cause is unknown, but its development is thought to be due to a combination of genetics and environmental factors. A diagnosis of anaplastic astrocytoma can only be made following an imaging procedure, along with a brain biopsy.
Frequent symptoms include headaches, drowsiness, vomiting, and changes in personality or mood. In some cases, symptoms such as seizures, vision problems, or weakness of the arms and legs can also occur.
A Word From Verywell
Anaplastic astrocytoma is very rare. If you are experiencing the symptoms highlighted above, it is more likely that your condition is not due to this type of cancer.
However, it is important to see a doctor if you experience any new neurological symptoms or if these symptoms continue over time. Remember, a diagnosis can only be made following a thorough clinical evaluation.
11 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
National Organization for Rare Diseases.Astrocytoma.
Genetic and Rare Diseases Information Center.Anaplastic astrocytoma.
Armstrong TS, Vera-bolanos E, Acquaye AA, Gilbert MR, Ladha H, Mendoza T.The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms.Neuro-oncology. 2016;18(2):252-60. doi:10.1093/neuonc/nov166
Grimm SA, Chamberlain MC.Anaplastic astrocytoma.CNS Oncol. 2016;5(3):145-157. doi:10.2217/cns-2016-0002
Stafstrom CE, Carmant L.Seizures and epilepsy: an overview for neuroscientists.Cold Spring Harb Perspect Med. 2015;5(6). doi:10.1101/cshperspect.a022426
Hirtz A, Rech F, Dubois-Pot-Schneider H, Dumond H.Astrocytoma: A hormone-sensitive tumor?Int J Mol Sci. 2020;21(23):9114. doi:10.3390/ijms21239114
Killela PJ, Pirozzi CJ, Reitman ZJ, et al.The genetic landscape of anaplastic astrocytoma.Oncotarget. 2014;5(6):1452-1457. doi:10.18632/oncotarget.1505
University of California San Francisco Brain Tumor Center.Anaplastic astrocytoma (grade III).
Huang J, Yu J, Tu L, Huang N, Li H, Luo Y.Isocitrate dehydrogenase mutations in glioma: from basic discovery to therapeutics development.Front Oncol. 2019;9:506. doi:10.3389/fonc.2019.00506
Valiyaveettil D, Malik M, Joseph D, Ahmed SF, Kothwal SA.Prognostic factors and outcomes in anaplastic gliomas: An institutional experience.South Asian J Cancer. 2018;7(1):1-4. doi:10.4103/sajc.sajc_55_17
Meet Our Medical Expert Board
Share Feedback
Was this page helpful?Thanks for your feedback!What is your feedback?OtherHelpfulReport an ErrorSubmit
Was this page helpful?
Thanks for your feedback!
What is your feedback?OtherHelpfulReport an ErrorSubmit
What is your feedback?
